Product Information
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Eywa Pharma Inc, priced at $0.1382 per EA under NDC 71930002013. Its NADAC has been published 42 times since Nov 5, 2025.
FDA first approved this application on Oct 30, 2017. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 7.5 mg/1; mg/1
Manufacturer
Eywa Pharma IncNDC
71930002013
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA210211FDA Approved
10/30/2017
TE Code
AA
On Market Since
7/13/2018
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 42 times since Nov 5, 2025, and over the history we have for it it has declined 7.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.1501 (Nov 12, 2025) |
| All-time low | $0.1379 (Apr 22, 2026) |
| 52-week high | $0.1501 |
| 52-week low | $0.1379 |
| Median price | $0.1389 |
| Average price | $0.1410 |
| Largest weekly change | -4.2% (Dec 17, 2025) |
| Weeks tracked | 42 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Eywa Pharma Inc, is $0.1382 per EA (NDC 71930002013), effective Aug 19, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 7.9%. It has been tracked across 42 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Since Nov 5, 2025, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.1379 (Apr 22, 2026) to a high of $0.1501 (Nov 12, 2025), with a median of $0.1389 per EA.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1272 per EA — about 8% below HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET.
Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 71930002013) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.